[{"e1": "Antidepressant", "e1id": "DDI-MedLine.d218.s0.e0", "e1o": 0, "e1o_origin": "0-13", "e1w": "Antidepressant", "e2": "warfarin", "e22id": "DDI-MedLine.d218.s0.e1", "e2o": 15, "e2o_origin": "15-22", "e2w": "warfarin", "words": [[0, "Antidepressant-warfarin"], [24, "interaction"], [36, "and"], [40, "associated"], [51, "gastrointestinal"], [68, "bleeding"], [77, "risk"], [82, "in"], [85, "a"], [87, "case-control"], [100, "study"], [105, "."]]}, {"e1": "lenalidomide", "e1id": "DDI-MedLine.d211.s0.e0", "e1o": 17, "e1o_origin": "17-28", "e1w": "lenalidomide", "e2": "CCI-779", "e22id": "DDI-MedLine.d211.s0.e3", "e2o": 112, "e2o_origin": "112-118", "e2w": "CCI-779", "words": [[0, "Phase"], [6, "I"], [8, "trial"], [14, "of"], [17, "lenalidomide"], [30, "and"], [34, "CCI-779"], [42, "in"], [45, "patients"], [54, "with"], [59, "relapsed"], [68, "multiple"], [77, "myeloma"], [84, ":"], [86, "evidence"], [95, "for"], [99, "lenalidomide-CCI-779"], [120, "interaction"], [132, "via"], [136, "P-glycoprotein"], [150, "."]]}, {"e1": "CCI-779", "e1id": "DDI-MedLine.d211.s0.e1", "e1o": 34, "e1o_origin": "34-40", "e1w": "CCI-779", "e2": "CCI-779", "e22id": "DDI-MedLine.d211.s0.e3", "e2o": 112, "e2o_origin": "112-118", "e2w": "CCI-779", "words": [[0, "Phase"], [6, "I"], [8, "trial"], [14, "of"], [17, "lenalidomide"], [30, "and"], [34, "CCI-779"], [42, "in"], [45, "patients"], [54, "with"], [59, "relapsed"], [68, "multiple"], [77, "myeloma"], [84, ":"], [86, "evidence"], [95, "for"], [99, "lenalidomide-CCI-779"], [120, "interaction"], [132, "via"], [136, "P-glycoprotein"], [150, "."]]}, {"e1": "lenalidomide", "e1id": "DDI-MedLine.d211.s0.e2", "e1o": 99, "e1o_origin": "99-110", "e1w": "lenalidomide", "e2": "CCI-779", "e22id": "DDI-MedLine.d211.s0.e3", "e2o": 112, "e2o_origin": "112-118", "e2w": "CCI-779", "words": [[0, "Phase"], [6, "I"], [8, "trial"], [14, "of"], [17, "lenalidomide"], [30, "and"], [34, "CCI-779"], [42, "in"], [45, "patients"], [54, "with"], [59, "relapsed"], [68, "multiple"], [77, "myeloma"], [84, ":"], [86, "evidence"], [95, "for"], [99, "lenalidomide-CCI-779"], [120, "interaction"], [132, "via"], [136, "P-glycoprotein"], [150, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s4.e0", "e1o": 21, "e1o_origin": "21-64", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s4.e3", "e2o": 366, "e2o_origin": "366-413", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "Weekly"], [7, "intramuscular"], [21, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [66, "injections"], [77, "("], [78, "0.2-0.5"], [86, "mg"], [88, "/"], [89, "kg"], [92, "body"], [97, "weight"], [103, ")"], [104, ","], [106, "in"], [109, "combination"], [121, "with"], [126, "daily"], [132, "administration"], [147, "of"], [150, "3"], [151, "-"], [152, "["], [153, "("], [154, "2-methyl-1,3-thiazol-4-yl"], [179, ")"], [181, "ethynyl"], [188, "]"], [190, "pyridine"], [199, "or"], [202, "vehicle"], [209, ","], [211, "were"], [216, "performed"], [226, "until"], [232, "the"], [236, "development"], [248, "of"], [251, "parkinsonian"], [264, "motor"], [270, "symptoms"], [279, "in"], [282, "either"], [289, "of"], [292, "the"], [296, "two"], [300, "experimental"], [313, "groups"], [320, "("], [321, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [367, "-"], [368, "["], [369, "("], [370, "2-methyl-1,3-thiazol-4-yl"], [395, ")"], [397, "ethynyl"], [404, "]"], [406, "pyridine"], [415, "versus"], [422, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle"], [474, ")"], [475, "."]]}, {"e1": "3 - [ ( 2-methyl-1,3-thiazol-4-yl ) ethynyl ] pyridine", "e1id": "DDI-MedLine.d161.s4.e1", "e1o": 150, "e1o_origin": "150-197", "e1w": "3 - [ ( 2-methyl-1,3-thiazol-4-yl ) ethynyl ] pyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s4.e3", "e2o": 366, "e2o_origin": "366-413", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "Weekly"], [7, "intramuscular"], [21, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [66, "injections"], [77, "("], [78, "0.2-0.5"], [86, "mg"], [88, "/"], [89, "kg"], [92, "body"], [97, "weight"], [103, ")"], [104, ","], [106, "in"], [109, "combination"], [121, "with"], [126, "daily"], [132, "administration"], [147, "of"], [150, "3"], [151, "-"], [152, "["], [153, "("], [154, "2-methyl-1,3-thiazol-4-yl"], [179, ")"], [181, "ethynyl"], [188, "]"], [190, "pyridine"], [199, "or"], [202, "vehicle"], [209, ","], [211, "were"], [216, "performed"], [226, "until"], [232, "the"], [236, "development"], [248, "of"], [251, "parkinsonian"], [264, "motor"], [270, "symptoms"], [279, "in"], [282, "either"], [289, "of"], [292, "the"], [296, "two"], [300, "experimental"], [313, "groups"], [320, "("], [321, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [367, "-"], [368, "["], [369, "("], [370, "2-methyl-1,3-thiazol-4-yl"], [395, ")"], [397, "ethynyl"], [404, "]"], [406, "pyridine"], [415, "versus"], [422, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle"], [474, ")"], [475, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s4.e2", "e1o": 321, "e1o_origin": "321-364", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s4.e3", "e2o": 366, "e2o_origin": "366-413", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "Weekly"], [7, "intramuscular"], [21, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [66, "injections"], [77, "("], [78, "0.2-0.5"], [86, "mg"], [88, "/"], [89, "kg"], [92, "body"], [97, "weight"], [103, ")"], [104, ","], [106, "in"], [109, "combination"], [121, "with"], [126, "daily"], [132, "administration"], [147, "of"], [150, "3"], [151, "-"], [152, "["], [153, "("], [154, "2-methyl-1,3-thiazol-4-yl"], [179, ")"], [181, "ethynyl"], [188, "]"], [190, "pyridine"], [199, "or"], [202, "vehicle"], [209, ","], [211, "were"], [216, "performed"], [226, "until"], [232, "the"], [236, "development"], [248, "of"], [251, "parkinsonian"], [264, "motor"], [270, "symptoms"], [279, "in"], [282, "either"], [289, "of"], [292, "the"], [296, "two"], [300, "experimental"], [313, "groups"], [320, "("], [321, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [367, "-"], [368, "["], [369, "("], [370, "2-methyl-1,3-thiazol-4-yl"], [395, ")"], [397, "ethynyl"], [404, "]"], [406, "pyridine"], [415, "versus"], [422, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle"], [474, ")"], [475, "."]]}, {"e1": "3 - [ ( 2-methyl-1,3-thiazol-4-yl ) ethynyl ] pyridine", "e1id": "DDI-MedLine.d161.s4.e3", "e1o": 366, "e1o_origin": "366-413", "e1w": "3 - [ ( 2-methyl-1,3-thiazol-4-yl ) ethynyl ] pyridine", "e2": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e22id": "DDI-MedLine.d161.s4.e4", "e2o": 422, "e2o_origin": "422-465", "e2w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "words": [[0, "Weekly"], [7, "intramuscular"], [21, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [66, "injections"], [77, "("], [78, "0.2-0.5"], [86, "mg"], [88, "/"], [89, "kg"], [92, "body"], [97, "weight"], [103, ")"], [104, ","], [106, "in"], [109, "combination"], [121, "with"], [126, "daily"], [132, "administration"], [147, "of"], [150, "3"], [151, "-"], [152, "["], [153, "("], [154, "2-methyl-1,3-thiazol-4-yl"], [179, ")"], [181, "ethynyl"], [188, "]"], [190, "pyridine"], [199, "or"], [202, "vehicle"], [209, ","], [211, "were"], [216, "performed"], [226, "until"], [232, "the"], [236, "development"], [248, "of"], [251, "parkinsonian"], [264, "motor"], [270, "symptoms"], [279, "in"], [282, "either"], [289, "of"], [292, "the"], [296, "two"], [300, "experimental"], [313, "groups"], [320, "("], [321, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [367, "-"], [368, "["], [369, "("], [370, "2-methyl-1,3-thiazol-4-yl"], [395, ")"], [397, "ethynyl"], [404, "]"], [406, "pyridine"], [415, "versus"], [422, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle"], [474, ")"], [475, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s5.e0", "e1o": 18, "e1o_origin": "18-61", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s5.e3", "e2o": 245, "e2o_origin": "245-292", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "After"], [6, "21"], [9, "weeks"], [15, "of"], [18, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [63, "treatment"], [72, ","], [74, "all"], [78, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [139, "animals"], [147, "displayed"], [157, "parkinsonian"], [170, "symptoms"], [178, ","], [180, "whereas"], [188, "none"], [193, "of"], [196, "the"], [200, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [246, "-"], [247, "["], [248, "("], [249, "2-methyl-1,3-thiazol-4-yl"], [274, ")"], [276, "ethynyl"], [283, "]"], [285, "pyridine-treated"], [302, "monkeys"], [310, "were"], [315, "significantly"], [329, "affected"], [337, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s5.e1", "e1o": 78, "e1o_origin": "78-121", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s5.e3", "e2o": 245, "e2o_origin": "245-292", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "After"], [6, "21"], [9, "weeks"], [15, "of"], [18, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [63, "treatment"], [72, ","], [74, "all"], [78, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [139, "animals"], [147, "displayed"], [157, "parkinsonian"], [170, "symptoms"], [178, ","], [180, "whereas"], [188, "none"], [193, "of"], [196, "the"], [200, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [246, "-"], [247, "["], [248, "("], [249, "2-methyl-1,3-thiazol-4-yl"], [274, ")"], [276, "ethynyl"], [283, "]"], [285, "pyridine-treated"], [302, "monkeys"], [310, "were"], [315, "significantly"], [329, "affected"], [337, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s5.e2", "e1o": 200, "e1o_origin": "200-243", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s5.e3", "e2o": 245, "e2o_origin": "245-292", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "After"], [6, "21"], [9, "weeks"], [15, "of"], [18, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], [63, "treatment"], [72, ","], [74, "all"], [78, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [139, "animals"], [147, "displayed"], [157, "parkinsonian"], [170, "symptoms"], [178, ","], [180, "whereas"], [188, "none"], [193, "of"], [196, "the"], [200, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [246, "-"], [247, "["], [248, "("], [249, "2-methyl-1,3-thiazol-4-yl"], [274, ")"], [276, "ethynyl"], [283, "]"], [285, "pyridine-treated"], [302, "monkeys"], [310, "were"], [315, "significantly"], [329, "affected"], [337, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s6.e0", "e1o": 349, "e1o_origin": "349-392", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s6.e1", "e2o": 394, "e2o_origin": "394-441", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "These"], [6, "behavioural"], [18, "observations"], [31, "were"], [36, "consistent"], [47, "with"], [52, "in"], [55, "vivo"], [60, "positron"], [69, "emission"], [78, "tomography"], [89, "dopamine"], [98, "transporter"], [110, "imaging"], [118, "data"], [122, ","], [124, "and"], [128, "with"], [133, "post-mortem"], [145, "stereological"], [159, "counts"], [166, "of"], [169, "midbrain"], [178, "dopaminergic"], [191, "neurons"], [198, ","], [200, "as"], [203, "well"], [208, "as"], [211, "striatal"], [220, "intensity"], [230, "measurements"], [243, "of"], [246, "dopamine"], [255, "transporter"], [267, "and"], [271, "tyrosine"], [280, "hydroxylase"], [292, "immunoreactivity"], [308, ","], [310, "which"], [316, "were"], [321, "all"], [325, "significantly"], [339, "higher"], [346, "in"], [349, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [395, "-"], [396, "["], [397, "("], [398, "2-methyl-1,3-thiazol-4-yl"], [423, ")"], [425, "ethynyl"], [432, "]"], [434, "pyridine-treated"], [451, "animals"], [459, "than"], [464, "in"], [467, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [528, "monkeys"], [535, "."]]}, {"e1": "3 - [ ( 2-methyl-1,3-thiazol-4-yl ) ethynyl ] pyridine", "e1id": "DDI-MedLine.d161.s6.e1", "e1o": 394, "e1o_origin": "394-441", "e1w": "3 - [ ( 2-methyl-1,3-thiazol-4-yl ) ethynyl ] pyridine", "e2": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e22id": "DDI-MedLine.d161.s6.e2", "e2o": 467, "e2o_origin": "467-510", "e2w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "words": [[0, "These"], [6, "behavioural"], [18, "observations"], [31, "were"], [36, "consistent"], [47, "with"], [52, "in"], [55, "vivo"], [60, "positron"], [69, "emission"], [78, "tomography"], [89, "dopamine"], [98, "transporter"], [110, "imaging"], [118, "data"], [122, ","], [124, "and"], [128, "with"], [133, "post-mortem"], [145, "stereological"], [159, "counts"], [166, "of"], [169, "midbrain"], [178, "dopaminergic"], [191, "neurons"], [198, ","], [200, "as"], [203, "well"], [208, "as"], [211, "striatal"], [220, "intensity"], [230, "measurements"], [243, "of"], [246, "dopamine"], [255, "transporter"], [267, "and"], [271, "tyrosine"], [280, "hydroxylase"], [292, "immunoreactivity"], [308, ","], [310, "which"], [316, "were"], [321, "all"], [325, "significantly"], [339, "higher"], [346, "in"], [349, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [395, "-"], [396, "["], [397, "("], [398, "2-methyl-1,3-thiazol-4-yl"], [423, ")"], [425, "ethynyl"], [432, "]"], [434, "pyridine-treated"], [451, "animals"], [459, "than"], [464, "in"], [467, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [528, "monkeys"], [535, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s8.e0", "e1o": 3, "e1o_origin": "3-46", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s8.e2", "e2o": 328, "e2o_origin": "328-375", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "In"], [3, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [64, "animals"], [71, ","], [73, "almost"], [80, "40"], [82, "%"], [84, "loss"], [89, "of"], [92, "tyrosine"], [101, "hydroxylase-positive"], [122, "norepinephrine"], [137, "neurons"], [145, "was"], [149, "found"], [155, "in"], [158, "locus"], [164, "coeruleus/A5/A7"], [180, "noradrenaline"], [194, "cell"], [199, "groups"], [205, ","], [207, "whereas"], [215, "the"], [219, "extent"], [226, "of"], [229, "neuronal"], [238, "loss"], [243, "was"], [247, "lower"], [253, "than"], [258, "15"], [260, "%"], [262, "of"], [265, "control"], [273, "values"], [280, "in"], [283, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [329, "-"], [330, "["], [331, "("], [332, "2-methyl-1,3-thiazol-4-yl"], [357, ")"], [359, "ethynyl"], [366, "]"], [368, "pyridine-treated"], [385, "monkeys"], [392, "."]]}, {"e1": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e1id": "DDI-MedLine.d161.s8.e1", "e1o": 283, "e1o_origin": "283-326", "e1w": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "e2": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "e22id": "DDI-MedLine.d161.s8.e2", "e2o": 328, "e2o_origin": "328-375", "e2w": "3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "words": [[0, "In"], [3, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated"], [64, "animals"], [71, ","], [73, "almost"], [80, "40"], [82, "%"], [84, "loss"], [89, "of"], [92, "tyrosine"], [101, "hydroxylase-positive"], [122, "norepinephrine"], [137, "neurons"], [145, "was"], [149, "found"], [155, "in"], [158, "locus"], [164, "coeruleus/A5/A7"], [180, "noradrenaline"], [194, "cell"], [199, "groups"], [205, ","], [207, "whereas"], [215, "the"], [219, "extent"], [226, "of"], [229, "neuronal"], [238, "loss"], [243, "was"], [247, "lower"], [253, "than"], [258, "15"], [260, "%"], [262, "of"], [265, "control"], [273, "values"], [280, "in"], [283, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3"], [329, "-"], [330, "["], [331, "("], [332, "2-methyl-1,3-thiazol-4-yl"], [357, ")"], [359, "ethynyl"], [366, "]"], [368, "pyridine-treated"], [385, "monkeys"], [392, "."]]}]